Correlation
The correlation between RNA and NVDA is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
RNA vs. NVDA
Compare and contrast key facts about Avidity Biosciences, Inc. (RNA) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RNA or NVDA.
Performance
RNA vs. NVDA - Performance Comparison
Loading data...
Key characteristics
RNA:
0.20
NVDA:
0.38
RNA:
0.91
NVDA:
0.84
RNA:
1.11
NVDA:
1.11
RNA:
0.33
NVDA:
0.51
RNA:
0.59
NVDA:
1.24
RNA:
29.76%
NVDA:
15.09%
RNA:
72.87%
NVDA:
58.96%
RNA:
-86.45%
NVDA:
-89.73%
RNA:
-40.99%
NVDA:
-9.56%
Fundamentals
RNA:
$3.73B
NVDA:
$3.39T
RNA:
-$3.00
NVDA:
$3.01
RNA:
0.00
NVDA:
1.64
RNA:
418.25
NVDA:
22.86
RNA:
2.81
NVDA:
39.31
RNA:
$8.93M
NVDA:
$148.52B
RNA:
$5.93M
NVDA:
$104.12B
RNA:
-$431.82M
NVDA:
$90.97B
Returns By Period
In the year-to-date period, RNA achieves a 6.53% return, which is significantly higher than NVDA's 0.63% return.
RNA
6.53%
-5.23%
-28.00%
15.34%
30.53%
N/A
N/A
NVDA
0.63%
21.07%
-2.24%
23.29%
93.53%
72.51%
74.01%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RNA vs. NVDA — Risk-Adjusted Performance Rank
RNA
NVDA
RNA vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Avidity Biosciences, Inc. (RNA) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
RNA vs. NVDA - Dividend Comparison
RNA has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RNA Avidity Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
Drawdowns
RNA vs. NVDA - Drawdown Comparison
The maximum RNA drawdown since its inception was -86.45%, roughly equal to the maximum NVDA drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for RNA and NVDA.
Loading data...
Volatility
RNA vs. NVDA - Volatility Comparison
Avidity Biosciences, Inc. (RNA) has a higher volatility of 26.12% compared to NVIDIA Corporation (NVDA) at 10.81%. This indicates that RNA's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
RNA vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Avidity Biosciences, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities